Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Cardio Diagnostics Holdings ( (CDIO) ) has issued an announcement.
Cardio Diagnostics Holdings, Inc. faced a compliance issue with Nasdaq’s minimum bid price requirement, as its stock price fell below $1.00 per share for 30 consecutive business days as of June 3, 2024. However, after being granted an extension until June 2, 2025, the company successfully regained compliance by May 28, 2025, as its stock price met the required threshold for 10 consecutive business days.
The most recent analyst rating on (CDIO) stock is a Buy with a $2.00 price target. To see the full list of analyst forecasts on Cardio Diagnostics Holdings stock, see the CDIO Stock Forecast page.
More about Cardio Diagnostics Holdings
Cardio Diagnostics Holdings, Inc. operates in the healthcare industry, focusing on developing and providing diagnostic solutions for cardiovascular diseases. The company aims to improve the detection and management of heart-related conditions through innovative technologies.
Average Trading Volume: 52,567
Technical Sentiment Signal: Sell
Current Market Cap: $7.39M
See more data about CDIO stock on TipRanks’ Stock Analysis page.